A Retrospective Study on the Diagnostic Value of Serum miR-206 in Rhabdomyosarcoma
- Determine whether circulating muscle-specific microRNAs, especially serum miR-206, are
potential biomarkers for rhabdomyosarcoma (RMS).
OUTLINE: Archived serum samples are analyzed for miR-206 expression.
PROJECTED ACCRUAL: A total of 15 samples from patients with alveolar rhabdomyosarcoma (RMS),
15 from patients with embryonal RMS, and 10 from patients without RMS will be accrued for
Serum miR-206 as a biomaker for RMS
Kyoto Prefectural University of Medicine
United States: Federal Government